Inscripta, a digital genome engineering company spun out of CU Boulder research, has just raised another $125 million in a Series D financing on the heels of launching its revolutionary product, The Onyx™. Inscripta is having a record funding year, also closing on $105 million in financing in late 2018 and early 2019. The company has raised $259.6 million in total and these new funds will help accelerate the expansion and commercialization of The Onyx™ .